COVID-19 vaccine development and roll-out: Where to from here?
The LSHTM-Charité Global Health Lecture Series brings together leading scientists from the UK, Germany and further afield to present cutting-edge research on pressing global health issues and to discuss the implications of their work for policy and practice. The series is supported by the Bill and Melinda Gates Foundation.
This seventh event of the LSHTM-Charité Global Health Lecture series will focus on COVID-19 vaccine development and roll-out, exploring hot topics in COVID-19 vaccine development and implementation including the vaccination of children and pregnant women and real-world challenges of running clinical trials during a pandemic.
Professor Beate Kampmann, Professor of Paediatric Infection & Immunity and Director of the Vaccine Center at London School of Hygience & Tropical Medicine (LSHTM), Professor Glenda Gray, President and Chief Executive Officer of the South African Medical Research Council (SAMRC) and others will speak at the event, providing insights into the status quo of COVID-19 vaccine development and roll-out, discussing real-world challenges and opportunities the pandemic has presented us with, and sharing a reflection on where we need to go from here.
Professor Veronika von Messling, Director-General Life Sciences, Germany Ministry of Education and Research (BMBF), will chair the event and will provide reflections on the policy context for COVID-19 vaccines in the current climate.
- Professor Beate Kampmann
Beate Kampmann is a professor of Paediatric Infection &Immunity at LSHTM. She directs the Vaccine Centre at LSHTM and divides her working time between London and The Gambia, West Africa, where she leads the vaccine research at the MRC Unit-The Gambia in West Africa.
She trained in Germany, France, the USA, South Africa and the UK and holds an MD from the University of Cologne and a PhD from Imperial College, UK. She is a Fellow of the Academy of Medical Sciences, the Royal College of Paediatrics and child health in the UK and the West African College of Physicians and an MRC Senior Researcher.
Her translational research portfolio focuses on innate and acquired immune responses to infection and vaccination, including in pregnant women and infants and the conduct of clinical trials of novel vaccines and adjuvants. She is the director of IMPRINT - the IMmunising PRegnant women and INfantsnetwork, a UKRI-GCRF-funded multi-disciplinary and global network of scientists, clinicians and public health representatives with a special interest in vaccines for pregnant women and newborns and has published over 250 articles.
Her team developed the LSHTM COVID-19 vaccine tracker which provides a comprehensive overview of the vaccine pipeline, results of clinical trials and global vaccine implementation.
- Professor Glenda Gray
Professor Glenda Gray is the first female President and CEO of the South African Medical Research Council (SAMRC). She was the Chair of the Research Committee on COVID-19, bringing together scientific evidence and experience to the Minister of Health and the National Coronavirus Command Council. Gray spearheads the SAMRC funding broadly and for COVID-19.
In her first five year tenure at the helm of the SAMRC, the organisation experienced five consecutive clean audits, transformed grant funding initiatives that significantly improved funding for young scientists, black African scientists and women; and established key collaborations and partnerships that will significantly progress scientific research. Gray studied medicine and paediatrics at Wits University where she remains a full Professor: Research in the School of Clinical Medicine.
A National Research Foundation A1-rated scientist, Gray is world-renowned for her research in HIV vaccines and interventions to prevent mother to child transmission of HIV. She co-founded and led, with James McIntyre, the globally eminent Perinatal HIV Research Unit at Chris Hani Baragwanath Hospital in Soweto. For this work, she and McIntyre received the Nelson Mandela Health and Human Rights Award in 2002. She is co-Principal Investigator of theNational Institutes of Health-funded HIV Vaccine Trials Network (HVTN) and directs the programme in Africa.
- Professor Veronika von Messling
Professor Dr Veronika von Messling is Director-General for Life Sciences at the German Federal Ministry of Education and Research. She obtained her veterinary degree and her doctorate degree in veterinary virology from the Veterinary School in Hannover, Germany.
After postdoctoral training at the Mayo Clinic in Rochester, MN, she was Assistant Professor at INRS-Institut Armand-Frappier in Laval, QC, and then Associate Professor at Duke-NUS Medical School, Singapore, before becoming Director of the Veterinary Division at Paul-Ehrlich-Institute, the German Federal Institute of Vaccines and Biomedicines, in Langen, Germany. Her expertise lies in the development of novel prophylactic and therapeutic strategies against infectious diseases.
Please note that the recording link will be listed on this page when available